ometendoОжирение и метаболизмObesity and metabolism2071-87132306-5524Endocrinology Research Centre10.14341/2071-8713-5222ometendo-5222Research ArticleСтатьиArticlesНарушения углеводного и жирового обмена при первичном гиперпаратиреозеNarusheniya uglevodnogo i zhirovogo obmena pri pervichnom giperparatireozeVoronenkoI V-MokryshevaN G-RozhinskayaL Ya-SyrkinA L-20081512200854№4 (2008)1824Copyright © Voronenko I.V., Mokrysheva N.G., Rozhinskaya L.Y., Syrkin A.L., 20082008Voronenko I.V., Mokrysheva N.G., Rozhinskaya L.Y., Syrkin A.L.Voronenko I.V., Mokrysheva N.G., Rozhinskaya L.Y., Syrkin A.L.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.omet-endojournals.ru/jour/article/view/5222ReferencesAkgun S. and Ertel N.H. Hyperparathyroidism and coexisting diabetes mellitus: altered carbohydrate metabolism // Archives of Internal Medicine 1978, 138: 1500-1502.Akgun S. and Ertel N.H. Hyperparathyroidism and coexisting diabetes mellitus: altered carbohydrate metabolism // Archives of Internal Medicine 1978, 138: 1500-1502.Austin M.A. et al. Hypertrigliceridemia as a cardiovascular risk factor // American J of Cardiology 1998; 81:7B-12B.Austin M.A. et al. Hypertrigliceridemia as a cardiovascular risk factor // American J of Cardiology 1998; 81:7B-12B.Baigent C. et al. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90056 participants in 14 randomized trials of statins // Lancet 2005, 366: 1267-1278Baigent C. et al. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90056 participants in 14 randomized trials of statins // Lancet 2005, 366: 1267-1278Bannon M.P. et al. The relationship between primary hyperparathyroidism and diabetes mellitus // Annals of Surgery 1988, 207: 430-433.Bannon M.P. et al. The relationship between primary hyperparathyroidism and diabetes mellitus // Annals of Surgery 1988, 207: 430-433.Bolland M.J. et al. Association between primary hyperparathyroidism and increased body weight: a meta-analysis // J Clin Endocrinology&Methabolism 2005, 90 (3): 1525-1530.Bolland M.J. et al. Association between primary hyperparathyroidism and increased body weight: a meta-analysis // J Clin Endocrinology&Methabolism 2005, 90 (3): 1525-1530.Bolland M.J. et al. Fat mass is an important predictor of parathyroid hormone levels in postmenopausal women // Bone 2006, 38(3): 317-321.Bolland M.J. et al. Fat mass is an important predictor of parathyroid hormone levels in postmenopausal women // Bone 2006, 38(3): 317-321.Bonora E. et al. Prevalence of insulin resistance in metabolic disorders: the Bruneck study // Diabetes 1998, 47: 1643-1649.Bonora E. et al. Prevalence of insulin resistance in metabolic disorders: the Bruneck study // Diabetes 1998, 47: 1643-1649.Chang C.J. et al. Ventricular tachycardia in a patient with primary hyperparathyroidism // Pacing Clin Electrophysiol 2000, 23: 534-537.Chang C.J. et al. Ventricular tachycardia in a patient with primary hyperparathyroidism // Pacing Clin Electrophysiol 2000, 23: 534-537.Cheung P.S. et al. Effect of hyperparathyroidism on the control of diabetes mellitus // Surgery 1986, 100: 1039-1047.Cheung P.S. et al. Effect of hyperparathyroidism on the control of diabetes mellitus // Surgery 1986, 100: 1039-1047.Christensson T. and Einarsson K. Serum lipids before and after parathyroidectomy in patients with primary hyperparathyroidism // Clinica Chemica Acta 1977, 78: 411-415.Christensson T. and Einarsson K. Serum lipids before and after parathyroidectomy in patients with primary hyperparathyroidism // Clinica Chemica Acta 1977, 78: 411-415.Christiansen P. et al. Primary hyperparathyroidism: whole-body bone mineral density in surgically treated Danish patients: a three-year follow-up study // Bone 1999, 25: 597-602.Christiansen P. et al. Primary hyperparathyroidism: whole-body bone mineral density in surgically treated Danish patients: a three-year follow-up study // Bone 1999, 25: 597-602.Dalberg K. et al. Cardiac function in primary hyperparathyroidism before and after operation. An echocardiographic study // Eur J Surg 1996, 162: 171-176.Dalberg K. et al. Cardiac function in primary hyperparathyroidism before and after operation. An echocardiographic study // Eur J Surg 1996, 162: 171-176.De la Torre N.G. et al. Parathyroid adenomas and cardiovascular risk // Endocrine-related cancer 2003, 10: 309-322.De la Torre N.G. et al. Parathyroid adenomas and cardiovascular risk // Endocrine-related cancer 2003, 10: 309-322.DeFronzo R.A. and Lang R. Hypophosphatemia and glucoseintolerance: evidence for tissue insensitivity to insulin // New England J of Medicine 1980, 303: 1259-1263.DeFronzo R.A. and Lang R. Hypophosphatemia and glucoseintolerance: evidence for tissue insensitivity to insulin // New England J of Medicine 1980, 303: 1259-1263.Delfini E., Petramala L. et al. Circulating leptin and adiponectin levels in patients with primary hyperparathyroidism // Metabolism 2007, 56(1): 30-36.Delfini E., Petramala L. et al. Circulating leptin and adiponectin levels in patients with primary hyperparathyroidism // Metabolism 2007, 56(1): 30-36.Dominiczak A.F., Lyall F., Morton J.J. et al. Blood pressure, left ventricular mass and intracellular calcium in primary hyperparathyroidism.// Clin Sci 1990, 78: 127-132.Dominiczak A.F., Lyall F., Morton J.J. et al. Blood pressure, left ventricular mass and intracellular calcium in primary hyperparathyroidism.// Clin Sci 1990, 78: 127-132.Dorheim M.A. et al. Osteoblastic gene expression during adipogenesis in hematopoetic supporting murine bone marrow stromal cells // J Cell Physiol 1993, 154: 317-328.Dorheim M.A. et al. Osteoblastic gene expression during adipogenesis in hematopoetic supporting murine bone marrow stromal cells // J Cell Physiol 1993, 154: 317-328.Erem C. et al. Blood coagulation, fibrinolysis and lipid profile in patients with primary hyperparathyroidism: increased plasma factor VII and X activities and D-dimer levels // Exp Cin Endocrinol Diabetes 2008, 16: 324-330.Erem C. et al. Blood coagulation, fibrinolysis and lipid profile in patients with primary hyperparathyroidism: increased plasma factor VII and X activities and D-dimer levels // Exp Cin Endocrinol Diabetes 2008, 16: 324-330.Grey A. and Reid I. Body weight and bone mineral density in hyperparathyroidism // Ann Intern Med 1995, 123: 732.Grey A. and Reid I. Body weight and bone mineral density in hyperparathyroidism // Ann Intern Med 1995, 123: 732.Haap M. et al. Association of serum phosphate levels with glucose tolerance, insulin sensitivity and insulin secretion in non-diabetic subjects // Eur J Clin Nutr 2006, 60(6): 734-739.Haap M. et al. Association of serum phosphate levels with glucose tolerance, insulin sensitivity and insulin secretion in non-diabetic subjects // Eur J Clin Nutr 2006, 60(6): 734-739.Hagstroem E. et al. Normalized dyslipidemia after parathyroidectomy in mild primary hyperparathyroidism: population based study over five years // Clin Endocrinol 2002, 56(2): 253-260.Hagstroem E. et al. Normalized dyslipidemia after parathyroidectomy in mild primary hyperparathyroidism: population based study over five years // Clin Endocrinol 2002, 56(2): 253-260.Hagstroem E. et al. Metabolic abnormalities in patients with normocalcemic hyper-parathyroidism detected at a population-based screening // European J of Endocrinology 2006, 155: 33-39.Hagstroem E. et al. Metabolic abnormalities in patients with normocalcemic hyper-parathyroidism detected at a population-based screening // European J of Endocrinology 2006, 155: 33-39.Hagstroem E. et al. Serum calcium is independently associated with insulin sensitivity measured with euglycemic-hyperinsulinaemic clamp in community-based cohort // Diabetologia 2007, 50 (2): 317-324.Hagstroem E. et al. Serum calcium is independently associated with insulin sensitivity measured with euglycemic-hyperinsulinaemic clamp in community-based cohort // Diabetologia 2007, 50 (2): 317-324.Hedback G. and Oden A. Increased risk of death from PHPT-an update // Eur J Clin Invest 1998, 28: 271-276.Hedback G. and Oden A. Increased risk of death from PHPT-an update // Eur J Clin Invest 1998, 28: 271-276.Kautzky-Willer A. et al. Insulin secretion, insulin sensitivity and hepatic insulin extraction in primary hyperparathyroidism before and after surgery // Clinical Endocrinology 1992, 37: 147-155.Kautzky-Willer A. et al. Insulin secretion, insulin sensitivity and hepatic insulin extraction in primary hyperparathyroidism before and after surgery // Clinical Endocrinology 1992, 37: 147-155.Knaheli A.A. et al. Prevalence of glucose intolerance in primary hyperparathyroidism and the benefit of parathyroidectomy // Diabetes Metab Res Rev 2007, 23(1): 43-48.Knaheli A.A. et al. Prevalence of glucose intolerance in primary hyperparathyroidism and the benefit of parathyroidectomy // Diabetes Metab Res Rev 2007, 23(1): 43-48.Kosch M. et al. Studies on flow-mediated vasodilatation and intima-media thickness of the brachial artery in patients with primary hyperparathyroidism // Am J Hypertens 2000, 13: 759-764.Kosch M. et al. Studies on flow-mediated vasodilatation and intima-media thickness of the brachial artery in patients with primary hyperparathyroidism // Am J Hypertens 2000, 13: 759-764.Krauss R.M. Atherogenicity of triglyceride rich lipoproteins// American J of cardiology 1998, 81: 13B-17B.Krauss R.M. Atherogenicity of triglyceride rich lipoproteins// American J of cardiology 1998, 81: 13B-17B.Kumar S. et al. Impaired glucose tolerance and insulin insensitivity in primary hyperparathyroidism // Clinical Endocrinology 1994, 40: 47-53Kumar S. et al. Impaired glucose tolerance and insulin insensitivity in primary hyperparathyroidism // Clinical Endocrinology 1994, 40: 47-53Lacour B. et al. Serum lipoprotein disturbances in primary and secondary hyperparathyroidism and effects of parathyroidectomy // Amercian J of Kidney Diseases 1986, 8: 422-429Lacour B. et al. Serum lipoprotein disturbances in primary and secondary hyperparathyroidism and effects of parathyroidectomy // Amercian J of Kidney Diseases 1986, 8: 422-429Ljunghall S. et al. Diabetes mellitus, glucose tolerance and insulin response to glucose in patients with primary hyperparathyroidism before and after parathyroidectomy // European Journal of Clinical Investigation 1983, 13: 373-377.Ljunghall S. et al. Diabetes mellitus, glucose tolerance and insulin response to glucose in patients with primary hyperparathyroidism before and after parathyroidectomy // European Journal of Clinical Investigation 1983, 13: 373-377.Lundgren E. et al. Case-control study on symptoms and signs of asymptomatic primary hyperparathyroidism // Surgery 1998, 124: 980-986.Lundgren E. et al. Case-control study on symptoms and signs of asymptomatic primary hyperparathyroidism // Surgery 1998, 124: 980-986.McCarty M.F. and Thomas C.A. PTH excess may promote weight gain by impeding catecholamine-induced lipolysis-implications for the impact of calcium, vitamin D, and alcohol on body weight // Med Hypotheses 2003, 61: 535-542.McCarty M.F. and Thomas C.A. PTH excess may promote weight gain by impeding catecholamine-induced lipolysis-implications for the impact of calcium, vitamin D, and alcohol on body weight // Med Hypotheses 2003, 61: 535-542.NIH Consensus Development Conference Statement. Triglyceride, high density lipoprotein, and coronary heart disease. NIH Development Panel on Triglyceride, High density lipoproteins and coronary heart disease // J of the American Medical Association 1993, 269: 505-510.NIH Consensus Development Conference Statement. Triglyceride, high density lipoprotein, and coronary heart disease. NIH Development Panel on Triglyceride, High density lipoproteins and coronary heart disease // J of the American Medical Association 1993, 269: 505-510.Piovesan A. et al. Left ventricular hypertrophy in primary hyperparathyroidism. Effects of successful parathyroidectomy // Clin Endocrinol 1999, 50: 321-328.Piovesan A. et al. Left ventricular hypertrophy in primary hyperparathyroidism. Effects of successful parathyroidectomy // Clin Endocrinol 1999, 50: 321-328.Prager R. et al. Peripheral insulin resistance in primary hyperparathyroidism // Metabolism 1983, 32: 800-805.Prager R. et al. Peripheral insulin resistance in primary hyperparathyroidism // Metabolism 1983, 32: 800-805.Prager R. et al. Evaluation of glucose tolerance, insulin secretion, and insulin action in patients with primary hyperparathyroidism before and after surgery // Calcified Tissue International 1990, 46: 1-4.Prager R. et al. Evaluation of glucose tolerance, insulin secretion, and insulin action in patients with primary hyperparathyroidism before and after surgery // Calcified Tissue International 1990, 46: 1-4.Procopio M. et al. The oral glucose tolerance test reveals a high frequency of both impaired glucose tolerance and undiagnosed Type 2 diabetes mellitus in primary hyperparathyroidism // Diabetic Medicine 2002, 19: 958-961.Procopio M. et al. The oral glucose tolerance test reveals a high frequency of both impaired glucose tolerance and undiagnosed Type 2 diabetes mellitus in primary hyperparathyroidism // Diabetic Medicine 2002, 19: 958-961.Procopio M. and Boretta G. Derangement of glucose metabolism in Hyperparathyroidism // J Endocrinol Invest 2003, 26(1): 1136-1142.Procopio M. and Boretta G. Derangement of glucose metabolism in Hyperparathyroidism // J Endocrinol Invest 2003, 26(1): 1136-1142.Quin J.D. and Gumpert J.R. Remission of non-insulin-dependent diabetes mellitus following resection of a parathyroid adenoma // Diabetic Medicine 1997, 14: 80-81.Quin J.D. and Gumpert J.R. Remission of non-insulin-dependent diabetes mellitus following resection of a parathyroid adenoma // Diabetic Medicine 1997, 14: 80-81.Richards M.L. and Thompson N.W. Diabetes mellitus with hyperparathyroidism: another indication for parathyroidectomy? // Surgery 1999, 126: 1160-1166.Richards M.L. and Thompson N.W. Diabetes mellitus with hyperparathyroidism: another indication for parathyroidectomy? // Surgery 1999, 126: 1160-1166.Scherrer U. and Sartori C. Defective nitric oxide synthesis. A link between metabolic insulin resistance, sympathetic overactivity and cardiovascular morbidity // European Journal of Endocrinology 2000, 142: 315-323.Scherrer U. and Sartori C. Defective nitric oxide synthesis. A link between metabolic insulin resistance, sympathetic overactivity and cardiovascular morbidity // European Journal of Endocrinology 2000, 142: 315-323.Stampfer M.J. et al. A prospective study of triglyceride level, low density lipoprotein particle diameter, and risk of myocardial infarction // J of the American Medical Association 1996, 276: 882-888.Stampfer M.J. et al. A prospective study of triglyceride level, low density lipoprotein particle diameter, and risk of myocardial infarction // J of the American Medical Association 1996, 276: 882-888.Taylor W.H. The prevalence of diabetes mellitus in patients with primary hyperparathyroidism and among their relatives // Diabetic Medicine 1991, 8: 683-687.Taylor W.H. The prevalence of diabetes mellitus in patients with primary hyperparathyroidism and among their relatives // Diabetic Medicine 1991, 8: 683-687.Taylor W.H., Khaleeli A.A. Prevalence of primary hyperparathyroidism in patients with diabetes mellitus // Diabetic Medicine 1997, 14: 386-389.Taylor W.H., Khaleeli A.A. Prevalence of primary hyperparathyroidism in patients with diabetes mellitus // Diabetic Medicine 1997, 14: 386-389.Valdemarsson S. et al. Increased plasma levels of islet amyloid polypeptide in patients with primary hyperparathyroidism // European J of Endocrinology 1996, 134: 320-325.Valdemarsson S. et al. Increased plasma levels of islet amyloid polypeptide in patients with primary hyperparathyroidism // European J of Endocrinology 1996, 134: 320-325.Valdemarsson S. et al. Metabolic abnormalities related to cardiovascular risk in primary hyperparathyroidism: effects of parathyroidectomy // J Inter Med 1998, 244(3): 241-249.Valdemarsson S. et al. Metabolic abnormalities related to cardiovascular risk in primary hyperparathyroidism: effects of parathyroidectomy // J Inter Med 1998, 244(3): 241-249.Vaziri N.D. et al. Lipid fractions in primary hyperparathyroidism before and after surgical cure // Acta Endocrinol (Copenh) 1983, 10: 539-542.Vaziri N.D. et al. Lipid fractions in primary hyperparathyroidism before and after surgical cure // Acta Endocrinol (Copenh) 1983, 10: 539-542.Wermers R.A. et al. Survival after diagnosis of PHPT: a population based study // Am J Med 1998, 104: 115-122.Wermers R.A. et al. Survival after diagnosis of PHPT: a population based study // Am J Med 1998, 104: 115-122.Westerdahl et al. Urate and arteriosclerosis in primary hyperparathyroidism // Clin Endocrinol 2001, 54(6): 805-811.Westerdahl et al. Urate and arteriosclerosis in primary hyperparathyroidism // Clin Endocrinol 2001, 54(6): 805-811.
The authors declare that there are no conflicts of interest present.